China · Delayed Price · Currency is CNY Huaxia Eye Hospital Group Statistics
Total Valuation
SHE:301267 has a market cap or net worth of CNY 13.47 billion. The enterprise value is 10.84 billion.
| Market Cap | 13.47B |
| Enterprise Value | 10.84B |
Important Dates
The next estimated earnings date is Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | Dec 22, 2025 |
Share Statistics
SHE:301267 has 832.47 million shares outstanding. The number of shares has decreased by -0.60% in one year.
| Current Share Class | 832.47M |
| Shares Outstanding | 832.47M |
| Shares Change (YoY) | -0.60% |
| Shares Change (QoQ) | +4.18% |
| Owned by Insiders (%) | 61.40% |
| Owned by Institutions (%) | 6.71% |
| Float | 160.65M |
Valuation Ratios
The trailing PE ratio is 29.31 and the forward PE ratio is 25.68.
| PE Ratio | 29.31 |
| Forward PE | 25.68 |
| PS Ratio | 3.21 |
| PB Ratio | 2.39 |
| P/TBV Ratio | 2.84 |
| P/FCF Ratio | 18.26 |
| P/OCF Ratio | 14.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.36, with an EV/FCF ratio of 14.70.
| EV / Earnings | 23.43 |
| EV / Sales | 2.58 |
| EV / EBITDA | 11.36 |
| EV / EBIT | 17.12 |
| EV / FCF | 14.70 |
Financial Position
The company has a current ratio of 3.82, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.82 |
| Quick Ratio | 3.58 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.13 |
| Debt / FCF | 1.47 |
| Interest Coverage | 13.55 |
Financial Efficiency
Return on equity (ROE) is 7.68% and return on invested capital (ROIC) is 16.84%.
| Return on Equity (ROE) | 7.68% |
| Return on Assets (ROA) | 5.01% |
| Return on Invested Capital (ROIC) | 16.84% |
| Return on Capital Employed (ROCE) | 9.72% |
| Weighted Average Cost of Capital (WACC) | 6.80% |
| Revenue Per Employee | 511,731 |
| Profits Per Employee | 56,420 |
| Employee Count | 8,200 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 13.52 |
Taxes
In the past 12 months, SHE:301267 has paid 146.56 million in taxes.
| Income Tax | 146.56M |
| Effective Tax Rate | 24.49% |
Stock Price Statistics
The stock price has decreased by -14.16% in the last 52 weeks. The beta is 0.52, so SHE:301267's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | -14.16% |
| 50-Day Moving Average | 17.15 |
| 200-Day Moving Average | 18.60 |
| Relative Strength Index (RSI) | 41.42 |
| Average Volume (20 Days) | 4,878,517 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301267 had revenue of CNY 4.20 billion and earned 462.64 million in profits. Earnings per share was 0.55.
| Revenue | 4.20B |
| Gross Profit | 1.82B |
| Operating Income | 633.21M |
| Pretax Income | 598.57M |
| Net Income | 462.64M |
| EBITDA | 798.58M |
| EBIT | 633.21M |
| Earnings Per Share (EPS) | 0.55 |
Balance Sheet
The company has 3.89 billion in cash and 1.08 billion in debt, with a net cash position of 2.81 billion or 3.38 per share.
| Cash & Cash Equivalents | 3.89B |
| Total Debt | 1.08B |
| Net Cash | 2.81B |
| Net Cash Per Share | 3.38 |
| Equity (Book Value) | 5.63B |
| Book Value Per Share | 6.54 |
| Working Capital | 3.39B |
Cash Flow
In the last 12 months, operating cash flow was 943.26 million and capital expenditures -205.53 million, giving a free cash flow of 737.73 million.
| Operating Cash Flow | 943.26M |
| Capital Expenditures | -205.53M |
| Depreciation & Amortization | 165.38M |
| Net Borrowing | -450.64M |
| Free Cash Flow | 737.73M |
| FCF Per Share | 0.89 |
Margins
Gross margin is 43.41%, with operating and profit margins of 15.09% and 11.03%.
| Gross Margin | 43.41% |
| Operating Margin | 15.09% |
| Pretax Margin | 14.26% |
| Profit Margin | 11.03% |
| EBITDA Margin | 19.03% |
| EBIT Margin | 15.09% |
| FCF Margin | 17.58% |
Dividends & Yields
This stock pays an annual dividend of 0.26, which amounts to a dividend yield of 1.61%.
| Dividend Per Share | 0.26 |
| Dividend Yield | 1.61% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 56.54% |
| Buyback Yield | 0.60% |
| Shareholder Yield | 2.21% |
| Earnings Yield | 3.43% |
| FCF Yield | 5.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHE:301267 is 24.19, which is 49.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 24.19 |
| Price Target Difference | 49.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 8.26% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on July 11, 2023. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 11, 2023 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:301267 has an Altman Z-Score of 6.46 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.46 |
| Piotroski F-Score | 5 |